transcription activator-like effectors (tales) are a class of naturally occurring Dna-binding proteins found in the plant pathogen Xanthomonas sp. the Dna-binding domain of each tale consists of tandem 34-amino acid repeat modules that can be rearranged according to a simple cipher to target new Dna sequences. customized tales can be used for a wide variety of genome engineering applications, including transcriptional modulation and genome editing. Here we describe a toolbox for rapid construction of custom tale transcription factors (tale-tFs) and nucleases (talens) using a hierarchical ligation procedure. this toolbox facilitates affordable and rapid construction of custom tale-tFs and talens within 1 week and can be easily scaled up to construct tales for multiple targets in parallel. We also provide details for testing the activity in mammalian cells of custom tale-tFs and talens using quantitative reverse-transcription pcr and surveyor nuclease, respectively. the tale toolbox described here will enable a broad range of biological applications.
IntroDuctIon
Systematic reverse-engineering of the functional architecture of the mammalian genome requires the ability to perform precise perturbations on gene sequences and transcription levels. Tools capable of facilitating targeted genome editing and transcription modulation are essential for elucidating the genetic and epigenetic basis of diverse biological functions and diseases. The recent discovery of the TALE code 1, 2 has enabled the generation of custom TALE DNA-binding domains with programmable specificity [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . When coupled to effector domains, customized TALEs provide a promising platform for achieving a wide variety of targeted genome manipulations [3] [4] [5] 8, 11, 13, 14 . Previously, we reported efficient construction of TALEs with customized DNA-binding domains for activating endogenous genes in the mammalian genome 3 . Here we describe an improved protocol for rapid construction of customized TALEs and methods to apply these TALEs to achieve endogenous transcriptional activation [3] [4] [5] 8 and site-specific genome editing 4, 7, 9, [11] [12] [13] [14] [15] . Investigators should be able to use this protocol to construct TALEs for targets of their choice in less than 1 week.
Transcription activator-like effectors
TALEs are natural bacterial effector proteins used by Xanthomonas sp. to modulate gene transcription in host plants to facilitate bacterial colonization 16, 17 . The central region of the protein contains tandem repeats of 34-aa sequences (termed monomers) that are required for DNA recognition and binding [18] [19] [20] [21] (Fig. 1a) . Naturally occurring TALEs have been found to have a variable number of monomers, ranging from 1.5 to 33.5 (ref. 16) . Although the sequence of each monomer is highly conserved, they differ primarily in two positions termed the repeat variable diresidues (RVDs, 12th and 13th positions). Recent reports have found that the identity of these two residues determines the nucleotide-binding specificity of each TALE repeat and that a simple cipher specifies the target base of each RVD (NI = A, HD = C, NG = T, NN = G or A) 1, 2 . Thus, each monomer targets one nucleotide and the linear sequence of monomers in a TALE specifies the target DNA sequence in the 5′ to 3′ orientation. The natural TALE-binding sites within plant genomes always begin with a thymine 1, 2 , which is presumably specified by a cryptic signal within the nonrepetitive N terminus of TALEs. The tandem repeat DNA-binding domain always ends with a half-length repeat (0.5 repeat, Fig. 1a) . Therefore, the length of the DNA sequence being targeted is equal to the number of full repeat monomers plus two.
Comparison with other genome manipulation methods
For targeted gene insertion and knockout, there are several techniques that have been used widely in the past, such as homologous gene targeting [22] [23] [24] , transposases 25, 26 , site-specific recombinases 27 , meganucleases 28 and integrating viral vectors 29, 30 . However, most of these tools target a preferred DNA sequence and cannot be easily engineered to function at noncanonical DNA target sites. The most promising, programmable DNA-binding domain has been the artificial zinc-finger (ZF) technology, which enables arrays of ZF modules to be assembled into a tandem array and target new DNA-binding sites in the genome. Each finger module in a ZF array targets three DNA bases 31, 32 . In comparison, TALE DNA-binding monomers target single nucleotides and are much more modular than ZF modules. For instance, when two independent ZF modules are assembled into a new array, the resulting target site cannot be easily predicted based on the known binding sites for the individual finger modules. Perhaps the biggest caveat of ZFs is that most of the intellectual property surrounding the ZF technology platform is proprietary and expensive ( >$10,000 per target site). A public effort for ZF technology development also exists through the Zinc Finger Consortium, but the publicly available ZF modules can only target a subset of the 64 possible trinucleotide combinations [33] [34] [35] . TALEs theoretically can target any sequence and have already been used in many organisms with impressive success ( Table 1) . Although TALEs seem superior in many ways, ZFs have a much longer track record in DNA-targeting applications 32 , including their use in human clinical trials 36 . Despite their relatively recent development, early results with TALEs have been promising and it seems that they can be applied in the same way as ZFs for many A transcription activator-like effector toolbox for genome engineering . Assemblies of monomeric DNA-binding domains can be inserted into the appropriate TALE-TF or TALEN cloning backbones to construct customized TALE-TFs and TALENs. TALE-TFs are constructed by replacing the natural activation domain within the TALE C terminus with the synthetic transcription activation domain VP64 (ref. 3 ; Fig. 1c ). By targeting a binding site upstream of the transcription start site, TALE-TFs recruit the transcription complex in a site-specific manner and initiate gene transcription. TALENs are constructed by fusing a C-terminal truncation ( + 63 aa) of the TALE DNA-binding domain 4 with the nonspecific FokI endonuclease catalytic domain (Fig. 1d) . The + 63-aa C-terminal truncation has also been shown to function as the minimal C terminus sufficient for transcriptional modulation 3 . TALENs form dimers through binding to two target sequences separated by ~17 bases. Between the pair of binding sites, the FokI catalytic domains dimerize and function as molecular scissors by introducing doublestrand breaks (DSBs; Fig. 1d ). Normally, DSBs are repaired by the nonhomologous end-joining 45 pathway (NHEJ), resulting in small deletions and functional gene knockout. Alternatively, TALEN-mediated DSBs can stimulate homologous recombination, enabling site-specific insertion of an exogenous donor DNA template 4, 13 . We also present a short procedure for verifying correct TALE assembly by using colony PCR to verify the correct insert length followed by DNA sequencing. With our cloning procedure, we routinely achieve high efficiency (correct length) and high accuracy (correct sequence). The cloning procedure is modular in several ways: we can construct TALEs to target DNA sequences of different lengths, and the protocol is the same for producing either TALE-TFs or TALENs. The backbone vectors can be modified with different promoters to achieve cell type-specific expression. Our protocol includes functional assays for evaluating TALE-TF and TALEN activity in human cells. This step is important because we have observed some variability in TALE activity on the endogenous genome, possibly because of epigenetic repression and/or inaccessible chromatin at certain loci. For TALE-TFs, we perform quantitative reverse-transcription PCR (qRT-PCR) to quantify changes in gene expression. For TALENs, we use the Surveyor mutation detection assay (i.e., the base-mismatch cleaving endonuclease Cel2) to quantify NHEJ. Although these assays are standard and have already been described elsewhere 46, 47 , we feel that the functional characterization is integral to TALE production and therefore have presented it here with the assembly procedure. Other functional assays, such as plasmid-based reporter constructs 3, 7 , restriction sites destroyed by NHEJ 48 or other enzymes that detect DNA mismatch 49 , may also be used to validate TALE activity. Our protocol (Fig. 2) begins with the generation of a monomer library, which takes 1 d and can be reused for building many TALEs. Using the monomer library, several TALEs can be constructed in a single day with an additional 2 d for transformation and sequence verification. To assess TALE function on the endogenous genome, we take ~3 d to go from mammalian cell transfection to qRT-PCR or Surveyor results.
Comparison with other TALE assembly procedures
A number of TALE assembly procedures have described the use of Golden Gate cloning to construct customized TALE DNA-binding domains 3, [6] [7] [8] [9] [10] . These methods rely on the use of a large collection of plasmids (typically over 50 plasmids) encoding repeat monomers and intermediate cloning vectors. Our PCR-based approach requires substantially less initial plasmid preparation, as our monomer library can be amplified on one 96-well PCR plate, and it facilitates more rapid construction of custom TALEs. Plasmid-based amplification has a much lower mutation/error rate but, in our experience, the combination of a high-fidelity polymerase and the short length of the monomer template (~100 nt) results in accurate assembly. For building similar-length TALEs to those presented in this protocol, the plasmid-based approaches also require an additional transformation and colony selection that extends the time needed to build TALEs. Thus, these alternative assembly protocols require a greater time investment both up-front (for monomer library preparation) and on a recurring basis (for each new TALE). For laboratories seeking to produce TALEs quickly, our protocol requires only a few hours to prepare a complete monomer library and less than 1 d to proceed from monomers to the final transformation into bacteria.
Targeting limitations
There are a few key limitations with the TALE technology. Although the RVD cipher is known, it is still not well understood as to why different TALEs designed according to the same cipher act on their target sites in the native genome with different levels of activity. It is possible that there are yet-unknown sequence dependencies for efficient binding or site-specific constraints (e.g., chromatin states) that are responsible for differences in functional activity. Therefore, we suggest constructing at least two or three TALE-TFs or TALEN pairs for each target locus. In addition, it is possible that engineered TALEs can have off-target effects-i.e., binding unintended genomic loci-which can be difficult to detect without additional functional assays at these loci. Given the relatively early state of TALE technology development, these issues remain to be addressed in a conclusive manner.
Experimental design TALE-TF target site selection. The programmable nature of TALEs allows for a virtually arbitrary selection of target DNAbinding sites. As previously reported, the N terminus of the TALE requires that the target site begin with a thymine nucleotide. For TALE-TFs, we have been successfully targeting 14-to 20-bp sequences within 200 bp of the transcription start site (Fig. 1c) . It can be advantageous to select a longer sequence to reduce off-target activation, as it is known from reporter activation assays that TALEs interact less efficiently with targets containing more than one mismatching base. In our assembly protocol, we describe ligation of 18 monomers into a backbone containing a nucleotide-specific final 0.5 monomer; combined with the initial thymine requirement, this yields a total sequence specificity of 20 nt. Specifically, the TALE-TF-binding site takes the form 5′-TN 19 -3′. When selecting TALE-TF-targeting sites for modulating endogenous gene transcription, we recommend selecting multiple target sites within the proximal promoter region (targeting either the sense or antisense strand), as epigenetic and local chromatin dynamics might impede TALE binding. A-3′ (N = A, G, T or C). TALENs should have fewer off-target effects because of the dimerization requirement for the FokI nuclease, although no significant off-target effects have been observed in limited sequencing verifications 13 . Because DSB formation only occurs if the spacer between the left and right TALEN-binding sites (Fig. 1d) is approximately 14-20 bases, nuclease activity is restricted to genomic sites with both the specific sequences of the left TALEN and the right TALEN with this small range of spacing distances between those sites. These constraints should greatly reduce potential off-target effects.
TALE monomer design.
To ensure that all synthesized TALEs are transcribed at a similar level, all of the monomers have been optimized to share identical DNA sequences except in the variable diresidues, and they are codon-optimized for expression in human cells (Supplementary Data 1) . This should minimize any difference in translation due to codon availability.
Construction strategy. Synthesis of monomeric TALE DNA-binding domains in a precise order is challenging because of their highly repetitive nature. Previously 3 , we took advantage of codon redundancy at the junctions between neighboring monomers and devised a hierarchical ligation strategy to construct ordered assemblies of multiple monomers. In this protocol, we describe a similar strategy, but with several important improvements that make the procedure easier, more flexible and more reliable (Fig. 3) .
In our initial protocol 3 , the digestion and ligation steps were carried out separately with an intervening DNA purification step. This improved protocol adopts the powerful Golden Gate cloning technique [42] [43] [44] , requiring less hands-on time and resulting in a more efficient reaction. The Golden Gate procedure involves combining the restriction enzyme and ligase together in a single reaction with a mutually compatible buffer. The reaction is cycled between optimal temperatures for digestion and ligation. Golden Gate digestionligation capitalizes on Type IIs restriction enzymes, for which the recognition sequence is spatially separated from where the cut is made. During a Golden Gate reaction, the correctly ligated products no longer contain restriction enzyme recognition sites and cannot be further digested. In this manner, Golden Gate drives the reaction toward the correct ligation product, as the number of cycles of digestion and ligation increases.
For the hierarchical ligation steps, we have optimized our previous cloning strategy for faster TALE production. The improved design takes advantage of a circularization step that allows only properly assembled hexameric intermediates to be preserved (Fig. 3) . Correctly ligated hexamers consist of six monomers ligated together in a closed circle, and incomplete ligation products are left as linear DNA. After this ligation step, an exonuclease degrades all noncircular DNA, leaving intact only the complete circular hexamers. Without circularization and exonuclease treatment, the correct ligation product would need to be gel purified before proceeding. The combination of Golden Gate digestion-ligation and circularization reduces the overall hands-on time required for TALE assembly.
Primer design for monomer library preparation. Each monomer in the tandem repeat must have its position uniquely specified. The monomer primers are designed to add ligation adaptors that enforce this positioning. Our protocol uses a hierarchical ligation strategy: For the 18-mer tandem repeat, we first ligate monomers into hexamers. Then, we ligate three hexamers together to form the 18-mer. By breaking down the assembly into two steps, we do not need unique ligation junctions for each monomer in the 18-mer. Instead, the same set of ligation junctions internal to each hexamer are reused in all three hexamers (first ligation step), whereas unique (external) ligation junctions are used to flank each hexamer (second ligation step). As shown in Figure 4 , the internal primers used to amplify the monomers within each hexamer are the same, but the external primers differ between the hexamers. By reusing the same internal primers between different hexamers, our protocol minimizes the number of primers necessary for monomer amplification.
Controls.
As a negative control for Golden Gate assembly, we recommend performing a separate reaction with only the TALE-TF or TALEN backbone. Transformation of this negative control should result in few or no colonies because of the omission of the tandem repeats and resulting religation of the toxic ccdB insert. After completing the TALE cloning, we use colony PCR or restriction digests to screen for correct length clones. For the final verification of proper assembly, we sequence the entire length of the tandem repeats. Owing to limits in Sanger sequencing read length, other TALE assembly protocols have difficulty sequencing the entire tandem repeat region 7, 9, 10 . The similarity of the monomers within the region makes primer annealing to specific monomers impossible. We have overcome this problem by slightly modifying the codon usage at the 5′ end of monomer 7 to create a unique annealing site, so that a TALE with an 18-mer DNA-binding array can be verified through a combination of three staggered sequencing reads. Specifically, during the monomer amplification, the codons for the first five amino acids in monomer 7 are mutated
Box 1 | Building TALEs that target DNA sequences of different lengths
In the main protocol, we present a hierarchical ligation strategy for the construction of TALEs that contain 18 full monomer repeats; however, the general approach can be easily adapted to construct TALEs of any length. These TALEs containing 18 full repeat monomers bind to 20-bp DNA sequences, where the first and last bases are specified by the N terminus and the 0.5 repeat, respectively (Fig. 1a) . We chose this length because, empirically, we have observed that 20-bp sequences tend to be unique within the human genome. Nevertheless, for different species (e.g., with larger or more repetitive genomes) or for repetitive regions within the human genome, it can be advantageous to construct longer or shorter TALEs. For certain genomic loci, it might also be difficult to identify TALEN target sites that satisfy the spacing constraints when the binding sites for both left and right TALENs are restricted to 20-bp sequences.
Our protocol is easily modified for the construction of TALEs containing up to 24 full monomer repeats by changing the order in which particular primers are used during the preparation of the monomer library plate (as described in Procedure Steps 1-9�). All other steps remain essentially the same. A plate of monomer amplification primers (similar to Fig. 4) can be prepared for building TALEs with 24 full monomer repeats, which bind to 26-bp DNA sequences, as illustrated below. In this case, a fourth circular hexamer, corresponding to monomers 19� through 24, is also built and treated identically as the other three circular hexamers (1-6, 7-12 and 13-18). For building shorter TALEs, only a single change to monomer amplification is needed: the final monomer should be amplified with the Ex-R4 reverse primer. For example, to build TALEs with 17 monomers instead of 18, the monomer templates (NI, NG, NN, HD) should be amplified with the forward/reverse primer combination In-F5/Ex-R4. Note that during gel purification (Procedure Step 20) the desired PCR amplicon is a pentamer containing monomers 13-17 and it will run faster than the hexamers (1-6, 7-12). After purification, ensure that the pentameric and hexameric intermediates are used at an equimolar ratio in the final Golden Gate digestion-ligation. via PCR to use different but synonymous codons, creating a unique priming site without changing the encoded TALE protein. This modification allows each hexamer in the 18-mer to be sequenced with a separate sequencing read and requires only a standard read length of ~700 bp for complete sequence verification. For TALEs containing more than 18 full monomer repeats, we introduced a third unique priming site for sequencing at the 3′ end of the 18th monomer using a similar approach. For the construction of TALEs containing up to 24 full monomers with the entire tandem repeat region easily sequenced, see Box 1.
Design of functional validation assays. For TALE-TFs, qRT-PCR quantitatively measures the increase in transcription driven by the TALE-TF. For TALENs, the Surveyor assay provides a functional validation of TALEN cutting and quantifies the cutting efficiency of a particular pair of TALENs. These assays should be performed in the same cell type as intended for the TALE application, as TALE efficacy can vary between cell types, presumably because of differences in chromatin state or epigenetic modifications.
For qRT-PCR, we use commercially available probes to measure increased transcription of the TALE-TF-targeted gene. For most genes in the human or mouse genomes, specific probes can be purchased (e.g., TaqMan gene expression probes from Applied Biosystems). There are a wide variety of qRT-PCR protocols, and although we describe one of them here others can be substituted. For example, a more economical option is to design custom, transcript-specific primers (e.g., with NCBI Primer-BLAST) and use a standard fluorescent dye to detect amplified double-stranded DNA (e.g., SYBR Green).
For Surveyor, we follow the recommendations given by the assay manufacturer when designing specific primers for genomic PCR. We typically design primers that are ~30 nt long and with melting temperatures of ~65 °C. The primers should flank the TALEN target site and generate an amplicon of approximately 300-800 bp with the TALEN target site near the middle. During the design, we also check to make sure the primers are specific over the intended genome using NCBI Primer-BLAST (http:// www.ncbi.nlm.nih.gov/tools/primer-blast/). Before using the primers for Surveyor, the primers and specific PCR cycling parameters should be tested to ensure that amplification results in a single clean band. In difficult cases in which a single-band product cannot be achieved, it is acceptable to gel-extract the correct-length band before proceeding with heteroduplex reannealing and Surveyor nuclease digestion. ; Enzymatics, cat. no. L602L)  crItIcal Do not substitute the more commonly used T4 ligase. T7 ligase has 1,000-fold higher activity on the sticky ends than on the blunt ends and higher overall activity than commercially available concentrated T4 ligases. Adenosine 5′-triphosphate ( Ex-F4 5′-TGCGTCcgtctcCGAACCTTAAACCGGCCAACATACCggtctcGTGGGCTCACCCCAGAGCAGGTCG-3′
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Ex-R1 5′-GCTGACcgtctcCGTTCAGTCTGTCTTTCCCCTTTCCggtctcTAAGTCCGTGCGCTTGGCAC-3′
Ex-R2 5′-GCTGACcgtctcCGTTCAGTCTGTCTTTCCCCTTTCCggtctcAGCCGTGCGCTTGGCACAG-3′
Ex-R3 5′-GCTGACcgtctcCGTTCAGTCTGTCTTTCCCCTTTCCggtctcTCCCATGGGCCTGACATAACACAGGCAG CAACCTCTG-3′
Ex-R4 5′-GCTGACcgtctcCGTTCAGTCTGTCTTTCCCCTTTCCggtctcTGAGTCCGTGCGCTTGGCAC-3′
In-F2 5′-CTTGTTATGGACGAGTTGCCcgtctcGTACGCCAGAGCAGGTCGTGGC-3′
In-F3 5′-CCAAAGATTCAACCGTCCTGcgtctcGAACCCCAGAGCAGGTCGTG-3′
In-F4 5′-TATTCATGCTTGGACGGACTcgtctcGGTTGACCCCAGAGCAGGTCGTG-3′
In-F5 5′-GTCCTAGTGAGGAATACCGGcgtctcGCCTGACCCCAGAGCAGGTCGTG-3′
In-F6 5′-TTCCTTGATACCGTAGCTCGcgtctcGGACACCAGAGCAGGTCGTGGC-3′
In-R1 5′-TCTTATCGGTGCTTCGTTCTcgtctcCCGTAAGTCCGTGCGCTTGGCAC-3′
In-R2 5′-CGTTTCTTTCCGGTCGTTAGcgtctcTGGTTAGTCCGTGCGCTTGGCAC-3′
In-R3 5′-TGAGCCTTATGATTTCCCGTcgtctcTCAACCCGTGCGCTTGGCACAG-3′
In-R4 5′-AGTCTGTCTTTCCCCTTTCCcgtctcTCAGGCCGTGCGCTTGGCACAG-3′
In-R5 5′-CCGAAGAATCGCAGATCCTAcgtctcTTGTCAGTCCGTGCGCTTGGCAC-3′ bean and S1 nucleases 50, 51 . Of these, Cel1 has been applied extensively for mutation detection [52] [53] [54] and established protocols are available for its purification 52, 54 . (Fig. 3, stage 1 ). Mix forward and reverse primers for each of the 18 positions according to the first two rows (A and B) of Figure 4 and achieve a final concentration of 10 µM for each primer. If you are using multichannel pipettes, arrange the oligonucleotide primers in the order indicated in Figure 4 to allow for easy pipetting. Typically, prepare 50-µl mixes for each primer pair (40 µl of ddH 2 O, 5 µl of 100 µM forward primer, 5 µl of 100 µM reverse primer). Figure 4 ; each plate will contain a total of 72 PCRs (18 positions for each monomer × 4 types of monomers). Although it is acceptable to have smaller-volume PCRs, we typically make the monomer set in larger quantities, as one monomer library plate can be used repeatedly for the construction of many TALEs. Each PCR should be made up as follows to a total volume of 200 µl, and then split between the two 9�6-well plates so that each well contains a 100-µl PCR: 
2| Set up two 9�6-well monomer library plates according to the organization shown in
4|
After the reaction has completed, use gel electrophoresis to verify that monomer amplification was successful. Cast a 2% (wt/vol) agarose gel in 1× TBE electrophoresis buffer with 1× SYBR Safe dye. The gel should have enough lanes to run out 2 µl of each PCR product from Step 3. Run the gel at 15 V cm − 1 for 20 min. It is not necessary to check all 72 reactions at this step; it is sufficient to check all 18 reactions for one type of monomer template. Successful amplification should show an ~100-bp product. Monomers positioned at the ends of each hexamer (monomers 1, 6, 7, 12, 13 and 18) should be slightly longer than the other monomers because of the length difference of the longer external primers. ? troublesHootInG 5| Pool both of the 100-µl PCR plates into a single deep-well plate. Purify the combined reactions using the QIAquick 9�6 PCR purification kit according to the manufacturer's directions. Elute the DNA from each well using 100 µl of Buffer EB (included with the kit), prewarmed to 55 °C. Alternatively, PCR products can also be purified using individual columns found in standard PCR cleanup kits.  crItIcal step Before eluting the DNA, let the 9�6-well column plate air-dry, preferably at 37 °C, for 30 min on a clean Kimwipe so that all residual ethanol has enough time to evaporate. 
7|
Image the gel using a quantitative gel imaging system. Monomers 1, 6, 7, 12, 13 and 18 are ~170 bp in size, whereas the other monomers are ~150 bp in size (Fig. 5, lanes 1-6) . Make sure the exposure is short enough so that none of the bands are saturated.
8|
Quantify the integrated intensity of each PCR product band using ImageJ or other gel quantification software. Use the quantitative ladder with known DNA mass (5, 10, 20, 40 , 100 ng) to generate a linear fit and quantify the concentration of each purified PCR product. ? troublesHootInG 9| Adjust the plate of purified PCR products by adding Buffer EB so that each monomer has the same molar concentration. As monomers 1, 6, 7, 12, 13 and 18 are longer than the other monomers, it is necessary to adjust them to a slightly (Fig. 3, stage 2 ). Prepare one reaction tube for each hexamer. Using the monomer plate schematic (Fig. 4) , pipette 1 µl of each normalized monomer into the corresponding hexamer reaction tube. Repeat this for all hexamers. For example, for the target from Step 10, set up tube 1 (1 µl from each of G1, A2, A3, G4, E5 and A6), tube 2 (1 µl from each of E7, C8, C9�, A10, E11 and C12) and tube 3 (1 µl from each of D1, D2, B3, H4, B5 and B6). To construct a TALE with 18 full repeats, three separate hexamer tubes are used.  crItIcal step Pay close attention when pipetting the monomers; it is very easy to accidentally pipette from the wrong well during this step.
12| Assembling hexamers using Golden Gate digestion-ligation
13|
To perform a simultaneous digestion-ligation (Golden Gate) reaction to assemble each hexamer (Fig. 3, stage 2) , add the following reagents to each hexamer tube:  crItIcal step DTT is easily oxidized in air. It should be freshly made or thawed from aliquots stored at − 70 °C and used immediately.
14|
Place each hexamer tube in a thermocycler to carry out the Golden Gate reactions using the following cycling conditions for ~3 h: 15| Run out the ligation product on a gel to check for ~700-bp bands corresponding to the hexamer products (Fig. 5a,  lane (Fig. 3, stage 3) . During the Golden Gate reaction, only fully ligated hexamers should be able to circularize. PlasmidSafe exonuclease selectively degrades noncircular (incomplete) ligation products. Add the following reagents to each hexamer reaction tube: 17| Incubate each hexamer reaction tube with PlasmidSafe at 37 °C for 30 min; follow by inactivation at 70 °C for 30 min.  pause poInt After completion, the reaction can be frozen and continued later. The circular DNA should be stable for at least 1 week.
18|
Hexamer PCR (Fig. 3, stage 4) . Amplify each PlasmidSafe-treated hexamer in a 50-µl PCR using high-fidelity Herculase II polymerase and the hexamer forward and reverse primers (Hex-F and Hex-R; table 2). Add the following reagents to each PCR: 20| Gel purification of amplified hexamers. Because of the highly repetitive template, it is necessary to purify the amplified hexamer product from the other amplicons. Cast a 2% (wt/vol) agarose gel in 1× TBE electrophoresis buffer with 1× SYBR Safe dye. The gel should have enough lanes to run out each PCR product from Step 19� , and the comb size should be big enough to load 40-50 µl of PCR product. Include 1 µg of the 1-kb Plus DNA ladder in one lane. Run the gel at 15 V cm − 1 until there is separation of the 650-bp ladder band from neighboring bands. Use a clean razor blade to excise each hexamer band, which should be nearly aligned with the 650-bp band from the ladder (Fig. 5, lane 9�) . ! cautIon Wear appropriate personal protective equipment, including a face mask, to minimize risks associated with prolonged light or mutagenic DNA dye exposure.  crItIcal step Avoid any cross-contamination by ethanol sterilization of work surfaces, razor blades, etc. during the gel extraction and between each individual band excision.
? troublesHootInG 21| Purify the hexamer gel bands from Step 20 using the MinElute gel extraction kit according to the manufacturer's directions. Elute the DNA from each reaction using 20 µl of Buffer EB prewarmed to 55 °C. (Fig. 3, stage 5 ). Combine the hexamers and the appropriate TALE backbone vector (transcription factor or nuclease) in a Golden Gate digestion-ligation. For example, we will use a TALE backbone with NI as the 0.5 repeat for the target sequence in Step 10 as N 19� = A. For this ligation, a 1:1 molar ratio of insert to vector works well. Set up one reaction tube for each TALE. In addition, prepare a negative control ligation by including the TALE backbone vector without any hexamers.  crItIcal step As a negative control, set up a separate reaction substituting an equal volume of water in place of the purified hexamers (i.e., including only the TALEN or TALE-TF backbone).
26| Golden Gate assembly of hexamers into TALE backbone
27| Place the tubes from
Step 26 in a thermocycler to carry out the Golden Gate reactions using the following cycling conditions for ~4 h:  pause poInt Ligation products can be frozen at − 20 °C and stored for at least 1 month for transformation into bacteria at a later time.
28|
Although it is not necessary, it is possible to run out the ligation product on a gel to check for ~1.8-kbp band corresponding to the properly assembled 18-mer tandem repeat. To check the ligation product, cast a 2% (wt/vol) agarose gel in 1× TBE electrophoresis buffer with 2× SYBR Safe dye. The additional dye helps to visualize faint bands. Load 5 µl of the ligation product from Step 27. Include 1 µg of the 1-kb Plus DNA ladder in one lane. Run the gel at 15 V cm − 1 until there is clear separation of the 1,650-and 2,000-bp ladder bands. Alternatively, proceed directly to transformation (Step 29�) without running a gel; transformation is very sensitive and, even when a clear band cannot be visualized on the gel, there is often enough plasmid for transformation of high-competency cells. ? troublesHootInG Verifying the correct tale repeat assembly • tIMInG 3 d (4 h hands-on time) 29| Transformation. Transform the ligation products from Step 27 into a competent E. coli strain; in our lab, we use Stbl3 for routine transformation. Transformation can be done according to the protocol supplied with the cells. Briefly, add 5 µl of the ligation product to 50 µl of ice-cold chemically competent Stbl3 cells, incubate on ice for 5 min, incubate at 42 °C for 45 s, return immediately to ice for 5 min, add 250 µl of SOC medium, incubate at 37 °C for 1 h on a shaking incubator (250 r.p.m.), plate 100 µl of the transformation on an LB plate containing 100 µg ml − 1 ampicillin and incubate overnight at 37 °C.
30| Inspect all plates from
Step 29� for bacterial colony growth. Typically, we see few colonies on the negative control plates (only backbone in the Golden Gate digestion-ligation) and tens to hundreds of colonies on the complete TALE ligation plates.
? troublesHootInG 31| For each TALE plate, pick eight colonies to check the assembly fidelity. Use a sterile 20-µl pipette tip to touch a single colony, streak onto a single square on a prewarmed, new, gridded LB-ampicillin plate to save the colony, and then swirl the tip in 100 µl of distilled water to dissolve the colony for colony PCR. Repeat this procedure for all colonies to be checked, streaking each new colony into a separate square on the gridded LB-ampicillin plate. After finishing, incubate the gridded plate at 37 °C for at least 4 h to grow the colony streaks.
32|
Colony PCR. By using the colonies selected in Step 31 as templates, set up colony PCR to verify that the correctly assembled tandem 18-mer repeat has been ligated into the TALE backbone. We have found that the colony PCR is sensitive to excessive template concentration, and therefore we typically use 1 µl of the 100-µl colony suspension from Step 31. For colony PCR, use primers TALE-Seq-F1 and TALE-Seq-R1 for amplification ( 35| Image the gel and identify which colonies have the correct insert size. For an insert of 18 monomers (three hexamers ligated into the TALE backbone vector), the product should be a single band of size 2,175 bp (Fig. 5b, lane 1) . Incorrect ligation products will show bands of different sizes. In place of colony PCR, plasmid DNA from prepared clones can be digested with AfeI. In both backbones (TALE-TF and TALEN), AfeI cuts four times. For both backbones, one fragment contains the entire tandem repeat region and should be 2,118 bp in size for a correctly assembled 18-mer. For the TALE-TF backbone, the correct clone will produce four bands with sizes 165, 2,118, 3,435 and 3,544 bp (Fig. 5b, lane 2) . The 3,435-and 3,544-bp bands are difficult to separate on a 1% (wt/vol) agarose gel, and therefore a correct clone will show three bands with the middle 2,118-bp band indicating an intact tandem 18-mer repeat (Fig. 5b, lane 2) . For the TALEN backbone, the correct clone will produce four bands with sizes 165, 2,118, 2,803 and 3,236 bp. ? troublesHootInG 36| Miniprep and sequencing. For each clone with the correct band size, inoculate a colony from the gridded plate into 3 ml of LB medium with 100 µg ml − 1 ampicillin and incubate it at 37 °C in a shaking incubator overnight.
37|
Isolate plasmid DNA from overnight cultures using a QIAprep Spin miniprep kit according to the manufacturer's instructions.
38|
Verify the sequence of each clone by sequencing the tandem repeat region using sequencing primers (table 2) TALE-Seq-F1 (forward primer annealing just before the first monomer), TALE-Seq-F2 (forward primer annealing at the beginning of the seventh monomer) and TALE-Seq-R1 (reverse primer annealing after the final 0.5 monomer). For most TALEs, reads from all three primers are necessary to unambiguously verify the entire sequence. Reference sequences for each custom TALE can be generated using our free online software (http://taleffectors.com/tools/). After entering the target site sequence, our software generates a TALE-TF or TALEN reference sequence in either FASTA format or as an annotated GenBank vector map (*.gb file) that can be viewed using standard plasmid editor software (e.g., everyVECTOR, VectorNTI or LaserGene SeqBuilder). Detailed instructions can be found on our website. 
40|
Prepare DNA for transfection. Quantify the DNA concentration of the TALE plasmids used for transfection using reliable methods (such as UV spectrophotometry or gel quantification).  crItIcal step The DNA concentration of the TALE plasmids should be quantified to guarantee that an accurate amount of TALE DNA will be used during the transfection.  crItIcal step The Surveyor procedure (Steps 46A(iii-xv)) is carried out according to the manufacturer's protocol and is described in greater detail in the Surveyor manual. We provide brief details here, as mutation detection by mismatch endonuclease is not a common procedure for most laboratories.  crItIcal step When performing the Surveyor assay for the first time, we suggest carrying out the positive control reaction included with the Surveyor nuclease kit.
(iv) Perform PCR using the following cycling conditions: is important to make sure that there is only a single band corresponding to the intended product for the primer pair. The size of this band should be the same as calculated from the distance between the two primer annealing sites in the genome.  crItIcal step If multiple amplicons are generated from the PCR, redesign primers and reoptimize the PCR conditions to avoid off-target amplification. ? troublesHootInG (vi) Image the gel using a quantitative gel imaging system. Make sure the exposure is short enough so that none of the bands are saturated. Quantify the integrated intensity of each PCR product using ImageJ or other gel quantification software. Use the quantitative ladder with known DNA mass (5, 10, 20, 40, 100 ng) to generate a linear fit. Adjust the DNA concentration of the PCR product by diluting it with 1× Herculase II reaction buffer so that it is in the range of 25-80 ng µl
(vii) DNA heteroduplex formation. At this point, the amplified PCR product includes a mixture of both modified and unmodified genomic DNA (TALEN-modified DNA will have a few bases of sequence deletion near the TALEN cut site because of NHEJ exonuclease activity). For Surveyor mismatch detection, this mixture of products must first be melted and reannealed such that heteroduplexes are formed. DNA heteroduplexes contain strands of DNA that are slightly different but annealed (imperfectly) together. Given the presence of both unmodified and modified DNA in a sample, a heteroduplex may include one strand of unmodified DNA and one strand of TALEN-modified DNA. Heteroduplexes can also be formed from reannealing of two different TALEN-modified products, as NHEJ exonuclease activity can produce different mutations. To cross-hybridize wild-type and TALEN-modified PCR products into hetero-and homoduplexes, all strands are melted and then slowly reannealed (Fig. 6b) . Place 300 ng of the PCR product from Step 46A(vi) in a thermocycler tube and bring it to a total volume of 20 µl with 1× Herculase II reaction buffer. (viii) Perform cross-hybridization on the diluted PCR amplicon from Step 46A(vii) using the following cycling conditions: (ix) Surveyor Nuclease S digestion. To treat the cross-hybridized homo-and heteroduplexes using Surveyor Nuclease S to determine TALEN cleavage efficiency (Fig. 6b) , add the following components together on ice and mix by pipetting gently: (xii) Analyze data and calculate the level of gene activation using the ∆∆C t method 46, 55 . TALE-TF results from qRT-PCR assay of SOX2 activation in HEK29�3 cells are shown in Figure 6d ,e.  crItIcal step The ∆∆C t method assumes that amplification efficiency is 100% (i.e., the number of amplicons doubles after each cycle). For new probes (such as custom TaqMan probes), amplification from a template dilution series (spanning at least five orders of magnitude) should be performed to characterize amplification efficiency. For standard TaqMan gene expression assay probes, this is not necessary, as they are designed to have 100 ± 10% amplification efficiency. ? troublesHootInG ? troublesHootInG Troubleshooting advice can be found in table 3. antIcIpateD results TALE-TFs and TALENs can facilitate site-specific transcriptional modulation [3] [4] [5] 8 and genome editing 4,7,9�,11-15 (table 1) . TALENs can be readily designed to introduce double-stranded breaks at specific genomic loci with high efficiency. In our experience, a pair of TALENs designed to target the human AAVS1 locus is able to achieve up to 3.6% cutting efficiency in 29�3FT cells, as determined by Surveyor nuclease assay (Fig. 6a-c) . TALE-TFs can also robustly increase the mRNA levels of endogenous genes. For example, a TALE-TF designed to target the proximal promoter region of SOX2 in human cells is able to elevate the level of endogenous SOX2 gene expression by up to fivefold 3 (Fig. 6d,e) . The ability for TALE-TFs and TALENs to act at endogenous genomic loci is dependent on the chromatin state, as well as yet-to-be-determined mechanisms regulating TALE DNA binding 56, 57 . For these reasons, we typically build several TALE-TFs or TALEN pairs for each genomic locus we aim to target. These TALE-TFs and TALENs are designed to bind to neighboring regions around a specific target site, as some binding sites might be more accessible than others. The reason why some TALEs exhibit significantly lower levels of activity remains unknown, although it is likely to be due to position-or cell-state-specific epigenetic modifications preventing access to the binding site. Because of differences in epigenetic states between different cells, it is possible that TALEs that fail to work in a particular cell type might work in a different cell type. 
